Private equity investment will spur additional oversight, but investors and the community could benefit
Thomas Kluz
Advertisement
Thomas Kluz is a distinguished venture capitalist with over a decade of experience. He’s the Managing Director of Niterra Ventures, where his investments focus on energy, mobility, and healthcare. With deep expertise in healthcare-focused venture capital, he has a proven track record of success with various organizations, such as Qualcomm Ventures and Providence Ventures.
Articles by Thomas Kluz
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Medical Economics
1
Michigan pharmacist sentenced for $4M Medicare fraud scheme; ACLM publishes official position on lifestyle medicine for high-value, whole-person care; daily coffee may slow aging in serious mental illness – Morning Medical Update
2
The 10 most underused Medicare codes in primary care
3
Pharmacist brothers sentenced in $15M fraud scheme; noninvasive treatment for brain tumors; AI spots chronic stress in routine CT scans – Morning Medical Update
4
FDA approves IsoPSA diagnostic test to improve prostate biopsy decision-making
5
